Differentiation therapies work by targeting the molecular pathways that regulate cell differentiation. For instance, all-trans retinoic acid (ATRA) is used to treat acute promyelocytic leukemia (APL) by inducing the differentiation of immature blood cells into mature granulocytes. This approach has shown significant success in improving survival rates for APL patients.
